Aandeel BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen BioForce Nanosciences Holdings, Inc. Other OTC

Aandelen

BFNH

US09064C2061

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
BioForce Nanosciences Holdings, Inc. Announces CEO Changes
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BFNH
  4. Koers BFNH
  5. Nieuws BioForce Nanosciences Holdings, Inc.
  6. Andere talen
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU